Citius Oncology (CTOR)

• Market cap: $109M
• 1 day: -20.73%
• 5 days: 18.18%
• 1 month: -22.16%
• 3 months: -35.32%
• 6 months: 46.05%
• Year to date: 9.24%
• 1 year: 27.45%
• 5 years: -87.12%
• 10 years: -87.12%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.